Q3 2019
|
76 |
258,083 |
BRK-B, BAC, JPM, PG
|
13F-HR
|
10/16/2019 |
000113266819000012 |
Q2 2019
|
89 |
314,930 |
BRK-B, JPM, BAC, CVX
|
13F-HR
|
7/26/2019 |
000113266819000010 |
Q1 2019
|
84 |
317,936 |
XOM, CSCO, VZ, MRK
|
13F-HR
|
4/17/2019 |
000113266819000008 |
Q4 2018
|
171 |
442,975 |
JPM, BRK-B, CSCO, MRK
|
13F-HR
|
1/24/2019 |
000113266819000002 |
Q3 2018
|
168 |
692,629 |
JPM, HTGC, TSC, VBTX
|
13F-HR
|
10/25/2018 |
000113266818000012 |
Q2 2018
|
168 |
754,064 |
HTGC, TSC, IVC, TUSK
|
13F-HR
|
7/25/2018 |
000113266818000010 |
Q1 2018
|
163 |
799,080 |
KELYA, TSC, CARO, IVC
|
13F-HR
|
4/11/2018 |
000113266818000008 |
Q4 2017
|
165 |
892,523 |
VBTX, TSC, CASH, MSBI
|
13F-HR
|
1/23/2018 |
000113266818000003 |
Q3 2017
|
171 |
936,029 |
KELYA, TSC, IVC, YELL
|
13F-HR
|
10/23/2017 |
000113266817000010 |
Q2 2017
|
173 |
955,626 |
FSB, NLS, HZN, FTK
|
13F-HR
|
8/3/2017 |
000113266817000008 |
Q1 2017
|
173 |
916,893 |
FTK, NLS, HTGC, FSB
|
13F-HR
|
4/25/2017 |
000113266817000006 |
Q4 2016
|
179 |
1,005,130 |
HTGC, TISI, FSB, FTK
|
13F-HR
|
1/25/2017 |
000113266817000004 |
Q3 2016
|
185 |
964,738 |
HTGC, NPTN, VVI, TISI
|
13F-HR
|
10/28/2016 |
000113266816000037 |
Q2 2016
|
189 |
846,253 |
FTK, SUPN, NVAX, NPTN
|
13F-HR
|
7/27/2016 |
000113266816000035 |
Q1 2016
|
234 |
805,417 |
OZK, KBAL, HTGC, SRI
|
13F-HR
|
4/28/2016 |
000113266816000033 |
Q4 2015
|
177 |
761,300 |
SHOR, RDN, AAN.A, HMST
|
13F-HR
|
1/28/2016 |
000113266816000032 |
Q3 2015
|
178 |
767,232 |
SHOR, RDN, AAN.A, HMST
|
13F-HR
|
10/27/2015 |
000113266815000028 |
Q2 2015
|
190 |
850,211 |
RDN, AERIE PHARMACEUTICALS INC, ATRC, INT
|
13F-HR
|
7/30/2015 |
000113266815000025 |
Q1 2015
|
232 |
924,115 |
INT, ATRC, HW, VRNT
|
13F-HR
|
4/29/2015 |
000113266815000007 |
Q4 2014
|
236 |
832,378 |
ATRC, HW, SHOR, CALX
|
13F-HR
|
1/26/2015 |
000113266815000004 |
Q3 2014
|
243 |
942,209 |
HW, ATRC, LDRH, RNST
|
13F-HR
|
11/6/2014 |
000113266814000014 |
Q2 2014
|
242 |
1,035,769 |
HW, ATRC, MEI, FNBC
|
RESTATEMENT
|
8/22/2014 |
000113266814000011 |
Q1 2014
|
233 |
986,005 |
HW, EXTR, FNBC, EMERALD OIL INC
|
13F-HR
|
5/6/2014 |
000113266814000006 |
Q4 2013
|
238 |
1,133,775 |
EXTR, CALLIDUS SOFTWARE INC, RGEN, FRGI
|
13F-HR
|
2/10/2014 |
000113266814000003 |